---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074605"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:56:51.499381+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tivic Health appoints Christina Valauri to board; Karen Drexler resigns effective Sep 30

## Summary
- Christina Valauri appointed director effective July 1, 2024; will chair Nominations & Corp Gov Committee.
- Valauri brings 30+ years capital markets experience; served as advisor since April 2023.
- Karen Drexler resigns as director effective Sep 30, 2024; will remain as strategic advisor.
- 2024 annual meeting set for Aug 9; record date June 17; shareholder proposals due June 27.

## SEC filing metadata
- accession: 0000950170-24-074605
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.08, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/0000950170-24-074605-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/tivc-20240617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074605
- JSON: https://secwatch.observer/filing/0000950170-24-074605.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074605.txt

## Key facts
- Executive change
  Karen Drexler resigned as director at Valion Bio, Inc..
  - Action: resigned
  - Role: director
  source text: On June 17, 2024, Karen Drexler tendered her resignation from the Board and each of the Compensation Committee, Audit and Risk Committee and Nominations and Corporate Governance Committee thereof, in each case effective September 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/0000950170-24-074605-index.htm
- Executive change
  Christina Valauri was appointed as director at Valion Bio, Inc..
  - Action: appointed
  - Role: director
  source text: On June 17, 2024, the board of directors (the “Board”) of Tivic Health Systems, Inc. (the “Company”) appointed Christina Valauri as a director of the Company, effective July 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/0000950170-24-074605-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.